Live Breaking News & Updates on Parkinsons Dis|Page 1

Stay updated with breaking news from Parkinsons dis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Parkinson's breakthrough as new blood test could diagnose disease before symptoms appear

A new blood test could be help to diagnose Parkinson s disease before it triggers damage in the nervous system. ....

United States , Duke University , North Carolina , Laurie Sanders , Duke University School Of Medicine , Science Translational Medicine , Duke University School , Ctp Video , Autoplay Video , Parkinsons Disease New Blood Test , Parkinsons Disease New Test , Parkinsons Disease Breakthrough , How To Identify Parkinsons Disease Early , How To Diagnose Parkinsons Disease Early , Health News , Health Latest , Parkinsons Dis ,

Parkinson's Incidence 50% Higher Than Previously Thought

Clusters of Parkinson's disease cases seen in certain U.S. regions ....

United States , University Of Pennsylvania , Brian Fiske , Judy George , Allison Willis , Kaiser Permanente , Census Bureau , Ontario Health Care , Michaelj Fox Foundation , Kaiser Permanente North California , Honolulu Asia Aging Study , Rochester Epidemiology Project , Olmsted County , Rochester Epidemiology , Social Security , Medpage Today , Parkinsons Dis ,

Parkinson's disease: new real-world data available on safinamide

Parkinson’s disease: new real-world data available on safinamide
28th April 2021
ADVERTISEMENT FEATURE

Dr Jason Raw outlines key findings from the SYNPASES trial, which explored the tolerability of safinamide used as an adjunct therapy in patients with Parkinson s disease
Zambon has officially presented the results from SYNAPSES, its multinational, multicentre, retrospective/prospective cohort observational study that explored the tolerability of safinamide used as an adjunct therapy in 1,610 patients followed up to 12 months. The study was designed to include potentially all patients treated with safinamide as per clinical practice
1, and investigate the real-world use of safinamide in six European countries including the UK, particularly in patient populations not well represented in clinical trials such as those older than 75, those with psychiatric illnesses or those with relevant comorbidities. ....

Greater Manchester , United Kingdom General , United Kingdom , Unified Parkinson , Disease Rating Scale , Jason Raw , Fairfield General Hospital , Routine Clinical , Parkinsons Dis , Rel Disord , அதிகமானது மான்செஸ்டர் , ஒன்றுபட்டது கிஂக்டம் ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , ஒருங்கிணைந்த பார்கின்சன் , நோய் ரேடிஂக் அளவு , ஃபேர்ஃபீல்ட் ஜநரல் மருத்துவமனை , வழக்கமான மருத்துவ , பார்கின்சன்ஸ் திஸ் ,